Duodenal cancer most commonly spreads to nearby lymph nodes, the liver, the peritoneum (the lining of the abdominal cavity), and the lungs. It can also invade adjacent organs directly, particularly the pancreas. The pattern of spread depends on the tumor’s location within the duodenum, its size, and how deeply it has grown into the intestinal wall.
Local Invasion Into Nearby Organs
Before spreading to distant sites, duodenal cancer often grows through the intestinal wall and into surrounding structures. In a 40-year surgical review published in JAMA Surgery, 22% of patients had tumors that had invaded the pancreas by the time of surgery. Twenty percent had invasion into major blood vessels, and 10% had spread into the retroperitoneum, the tissue lining the back of the abdominal cavity. Larger tumors are more likely to invade these structures simply because they’ve had more time to grow. Transmural invasion, where the cancer penetrates all layers of the duodenal wall, is one of the strongest predictors of poor outcomes.
Lymph Node Spread Follows a Predictable Path
The lymph nodes surrounding the duodenum are the first stop for cancer cells traveling through the lymphatic system. The specific nodes at risk depend on where the tumor sits within the duodenum’s four sections.
For tumors in the first portion (closest to the stomach), the earliest nodes to receive cancer cells are those along the ligament connecting the liver to the duodenum, the nodes near the pylorus (the junction between the stomach and duodenum), and the nodes around the head of the pancreas. For tumors in the third and fourth portions (the lower segments), cancer drains toward lymph nodes along the superior mesenteric artery, which supplies blood to most of the small intestine.
Regardless of where the tumor originates, the lymph nodes immediately surrounding the pancreatic head are consistently at risk. These are considered “upstream” in the lymphatic flow for all duodenal tumors, making them a priority during surgical evaluation. Nodes along the hepatic artery and celiac axis can also be involved, representing a more advanced degree of lymphatic spread.
Liver, Peritoneum, and Lungs
When duodenal cancer spreads beyond the local area, it follows a pattern similar to other gastrointestinal cancers. The three most common distant sites are the peritoneum, the liver, and the lungs.
The liver is particularly vulnerable because venous blood from the duodenum drains directly into the portal vein system, giving cancer cells a direct route. Liver metastases can cause jaundice if they obstruct bile flow, or they may be detected on imaging before symptoms appear.
Peritoneal spread occurs when cancer cells seed the membrane lining the abdominal cavity. This can happen through direct extension once the tumor breaches the outer wall of the duodenum, or through lymphatic drainage that deposits cells across the peritoneal surface. Peritoneal involvement often causes fluid buildup in the abdomen (ascites), bloating, and worsening abdominal discomfort.
Lung metastases typically develop through the bloodstream and may not cause noticeable symptoms in early stages. They’re usually found during staging scans rather than from respiratory complaints.
Less Common Sites of Spread
While the liver, peritoneum, and lungs account for the vast majority of distant spread, duodenal cancer can occasionally reach other organs. Bone, brain, adrenal glands, and even the skin have been documented as metastatic sites, though these are rare. One published case report described a patient whose duodenal adenocarcinoma first presented as a skin lesion before the primary tumor was identified. These atypical presentations are the exception, but they illustrate that advanced disease can appear in unexpected locations.
How Spread Is Detected
Contrast-enhanced CT scanning is the primary tool for identifying where duodenal cancer has spread. It can detect enlarged lymph nodes, liver lesions, and peritoneal deposits with a sensitivity around 93% for gastrointestinal metastases. MRI adds detail in specific situations, particularly for evaluating bile duct obstruction or ruling out additional masses near the pancreas and duodenum.
PET-CT is especially useful for uncovering metastases that haven’t yet caused symptoms or that aren’t clearly visible on standard CT. It scans the entire body for areas of abnormal metabolic activity and plays an important role in initial staging, helping determine whether the cancer has spread beyond what other imaging shows.
Signs That Suggest Spread
The most common symptoms of duodenal cancer, whether localized or advanced, include abdominal pain, jaundice, bloating, vomiting, and gastrointestinal bleeding. As the disease spreads, symptoms tend to shift based on which organs are involved. Liver metastases can deepen jaundice and cause right-sided abdominal pain. Peritoneal spread often brings progressive bloating and loss of appetite as fluid accumulates. Weight loss and fatigue tend to worsen as the disease becomes more widespread.
These symptoms overlap heavily with earlier-stage disease and with many other conditions, which is one reason duodenal cancer is often diagnosed at an advanced stage.
Survival With Metastatic Disease
The prognosis for duodenal cancer depends heavily on how far it has spread at diagnosis. The overall five-year survival rate for small bowel adenocarcinoma (the category that includes duodenal cancer) is roughly 30%. For patients with stage IV disease, where cancer has reached distant organs, that number drops to between 3% and 5%. One large analysis placed the five-year survival rate for stage IV patients at 4.3%. Tumor size, the degree of wall invasion, and how abnormal the cancer cells look under a microscope all influence individual outcomes.